RECURRENT KIDNEY WILMS TUMOR
Clinical trials for RECURRENT KIDNEY WILMS TUMOR explained in plain language.
Never miss a new study
Get alerted when new RECURRENT KIDNEY WILMS TUMOR trials appear
Sign up with your email to follow new studies for RECURRENT KIDNEY WILMS TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare cancers: targeted drug shows promise
Disease control Recruiting nowThis study tests a drug called DS-8201a (trastuzumab deruxtecan) in children, teens, and young adults whose osteosarcoma, Wilms tumor, or desmoplastic small round cell tumor has come back or not responded to treatment. The drug works like a smart bomb, attaching to cancer cells a…
Matched conditions: RECURRENT KIDNEY WILMS TUMOR
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New chemo combo offers hope for kids with tough kidney cancer
Disease control Recruiting nowThis study tests two powerful chemotherapy combinations in children with a rare, aggressive kidney cancer called Wilms tumor. One group has newly diagnosed disease, the other has cancer that returned after initial treatment. The goal is to see if these drug mixes can stop the can…
Matched conditions: RECURRENT KIDNEY WILMS TUMOR
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC